In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Eleonora VardaroDipartimento di Farmacia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.ORCID 0009-0009-2451-2004 Adriana De LuciaArterra Bioscience Spa, 80142 Naples, Italy.
Danila FalangaArterra Bioscience Spa, 80142 Naples, Italy.
Annamaria CefarielloArterra Bioscience Spa, 80142 Naples, Italy.
Lucia RicciDipartimento di Farmacia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.ORCID 0009-0001-7479-6289 Giuditta VitielloArterra Bioscience Spa, 80142 Naples, Italy.
Ilaria ArraArterra Bioscience Spa, 80142 Naples, Italy.
Ritamaria Di LorenzoDipartimento di Farmacia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.ORCID 0000-0003-1406-6214 Gianfranco DirettoItalian National Agency for New Technologies, Energy, and Sustainable Development (ENEA), Green Bi Technology Laboratory, Casaccia Research Centre, 00123 Rome, Italy.ORCID 0000-0002-1441-0233 Olivia Costantina DemurtasItalian National Agency for New Technologies, Energy, and Sustainable Development (ENEA), Green Bi Technology Laboratory, Casaccia Research Centre, 00123 Rome, Italy.ORCID 0000-0003-3344-5754 Maria SulliItalian National Agency for New Technologies, Energy, and Sustainable Development (ENEA), Green Bi Technology Laboratory, Casaccia Research Centre, 00123 Rome, Italy.ORCID 0000-0002-6875-2546 Apostolos PappasCRB S.A., CH-1070 Puidoux, Switzerland.
Giovanni GrecoDipartimento di Farmacia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.ORCID 0000-0002-4632-4620 Sonia LaneriDipartimento di Farmacia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.ORCID 0000-0002-1173-1592 Maria Gabriella ColucciArterra Bioscience Spa, 80142 Naples, Italy.
Funding
European Union 101000373
6 · The paper itselfAbstract
The skin barrier is essential for maintaining epidermal homeostasis and preventing transepidermal water loss (TEWL). This study investigated the ability of a
Indexed as
BiomarkersCell DifferentiationEpidermisLipid MetabolismPlant ExtractsCeramidesFilaggrin ProteinsGlucosylceramidaseHumansKeratinocytesBiomarkersCeramidesFilaggrin ProteinsFLG protein, humanGlucosylceramidasePlant Extractsceramidescosmetic biotechnologyfilaggrinHyssopus officinalisinvolucrinplant cell cultureserine palmitoyltransferaseskin barriertransepidermal water lossβ-glucocerebrosidase
Identifiers
PMID42505409
PMCPMC13406663
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390